INTRODUCTION
Nuclear Regulatory Commission (NRC) Regulatory Guide 8.22 establishes regulations on the type and frequency of bioassays for workers exposed to inhaling natural uranium (U-nat) at ore-processing mills. The chemical compounds of uranium encountered in mill processing are uranium dioxide (U0"), the ore, and uranium oxide (U,0 S ), the product of the mill process.
Uranium dioxide is relatively insoluble in the lungs anu is generally treated as Y solubility clasa in the Tnternational Commission on Radiological Protection (ICRP) Lung Model dynamics.
On the other hand, U,0 o is 2 relatively soluble and Is generally treated as W-class matei.
Only two bioassay methods are mentioned in the guide, namely, urinalysis and in vivo lung counting. Minimum detection limits are specified as 5 ug/1 or less for urinalysis and 9 nCi or less for in vivo lung counting.
It is the purpose of this paper to study the frequency of sampling and the minimum detection limits as they apply to dose commitment to the lung and bone and to chemical toxicity to the kidney. 3 The AERIN Code, discussed in Appendix A, is J9ed to estimate the internal dose and organ burdens for inhalation Oi D-, W-, and Y-class natural uranium of 1-, 5-, and 10-um Activity Mean Aerodynamic Diameter (AMAD) particle sizes. The study focuses primarily on acute exposures with bioassay sampling periods of IS, 30, 100, and 200 days, corresponding to 2-week, 1-month, 3-month, and 6-month intervals. Some discussion is Included on long-term chronic exposures and the internal dose and organ burdens that might escape detection at the minimum detection levels required for bioassay samples.
METHODS
Runs of the AERIN Code were made for both acute and chronic inhalation exposure to natural uranium dust. The runs were made for three particle sizes: 1-, 5-, and 10-um AMAD of solubility classes, 0, W, and Y as described in the ICRP Lung Model.
For acute exposure, a single inhalation of 10 tiCi was assumed for input data. For the chronic case, 0.728 nCi was assumed inhaled each day, five days a week, 50 weeks a year (equivalent to a steady state of 0.500 nCi/day every date of the year, for code Input).
The specific activity of natural uranium was taken as 0.677 pCi/ug and the mm of effective energy (IEF) in the bone and lung aa 4.60 MeV/d?c<integration, as derived in Appendix B.
The fraction of U-nat moving from the blood after inhalation to the kidney was assumed to be 0.11, and the biological half-life in the kidney was taken as 15 days.
For bone, the fraction of U-nat moving from the 2 blood to the bone was assumed to be 0.33.
The biological half-life in the 2 bone was taken as 300 days.
The elimination rate for U-nat through urine as used in the code is
where t is time in days, A n represents the systemic burden at t = 1, and t > 1 day. For day 1,
where A. represents the activity entering the blood during day 1 (see Appendix C). On day 1, A" = A. .
As long as uranium deposits remain in any of the naso-pharynx (NP), tracheo-bronchial (TB) , pulmonary (PL), or pulmonary lymph (LY) regions, there is JI daily contribution from these regions to the blood. Thus there is always a "day 1" component in the blood. As shewn in Appendix C, the uranium content in the un lie at any time can be represented by the Is necessary to calculate the term 0.46 A. by hand and add it to the value printed out. to find the true urine activity.
Suppose now we want to find the maximum annual undetected absorbed dose to the lung from a single acute inhalation of Y-class U-nat of a given particle size if urine sampling is done semiannually (at 200-day intervals). The minimum detection.level for U-nat in the urine, 5 ug/1, corresponds to 4.7 pCi/day (5vg/l * 1.4 1/day x 0.677 pCi/ug; the specific acti"ity value is derived in Appendix B), We find the predicted urine activity from the computer printout for day 200 and add to it the value calculated for 0.46 A. (see Appendix C for an example). We then take the minimum detection level for U-nat in the urine (4.7 pCi/day) and divide it by the predicted value to obtain a scaling factor which can be applied to all of the other data printed out.
These calculations of absorbed dose to the lung and bone were converted to dose equivalents as shown in Appendix D. For maximum kidney burden, total kidney mass of 300 g was assumed.
We can find a scaling factor for the minimum detection limit for lung burden (9 nCi) in the same manner to determine what doses could be received without detection if an in vivo lung count were made annually.
(This is done for Y-class U-Nat only; urinalysis is an adequate protective bioassay for D-and W-class material, as will be discussed.)
For chronic exposure, a constant intake was assumed until equilibrium organ burdens were established and a constant urine activity was observed.
A scaling factor, found by using the equilibrium concentration in the urine, was applied to the equilibrium organ burdens from the computer printout to get the organ burderi and annual absorbed dose that would result. Tables 1-3 show the maximum doee equivalents for the lung and bone and the maximum specific organ burden in the kidney that might not be detected at a minimum uranium detection in the urine of 5 ng/1. An acute inhalation exposure is assumed.
RESULTS AND DISCUSSION

ACUTE EXPOSURE
The total inhalation entries represent the total amount necessary to give 5 ug/1 activity in the urine at the indicated interval after exposure. For example, if one were exposed to 5 um AMAD natural uranium of W solubility class, it would take an intake of 23.4 nCi to give 5 ug/1 in the urine 30 days after the inhalation exposure (Table 2) Even when D-and W-class materials are involved, the frequency of collecting and analyzing urine content has to be chosen with care. Table   4 shows the maximum time that can elapse between collection periods to prevent the specific kidney burden from exceeding 3 ug/g (1 kidney burden ). For Y-class solubility, the maximum time that may elapse between in vivo lung counts is i83 days if the annual dose equivalent to the 2 lung is to be <15 rem/year (1 lung burden ) and the minimum detection level by in vivo lung counting is 9 nCi (see Table 5 ), If only an annual count were made at a minimum detection level of 9 nCi, an annual dose equivalent of 16.8 rem could exist without being detected. These values were calculated using the biological half-life in the lung for 60% of the deposited material as 500 days.
If the biological half-life were shorter, then the annual dose equivalent to the lung would be larger. Table 5 shows the effect of biological half-life on the annual dose equivalent to the lung for an annual in vivo count with a minimum detection level of 9 nCi, Thus, to ensure a lung dose of ^15 rem/year from exposure to Y-class U-nat, semiannual (six-month) in vivo counts will be necessary.
CHRONIC EXPOSURE
Consider now the continuou. inhalation of U-nat at a low concentration.
After a more or less constant intake of uranium by inhalation, equilibrium will be established for the uranium deposited in the various organs In the body. This means that the amount of material in the organs will remain at some constant level as long as the intake continues. The time to reach equilibrium is dependent primarily on the biological half-life of the material in the organ. The equilibrium level is dependent not only on the biological half-life but also on the intake rate, particle size, solubility, and fractional distribution from the blood to the organ during transport through the blood stream. Table 6 lists the time of continuous intake required to reach 99% of equilibrium in the organs listed.
If one aspuiat.: a continuous inhalation exposure until an equilibrium concentration is achieved in the urine and if tne level of intake is just sufficient to produce an equilibrium urinf> concentration of 5 Pg/1, what will be the annual dose equivalents to the lung and bone and the specific kidney burden? These values are given in Table 7 . Values are the same for all particle sizes. These data show that for long-term chronic exposure to D-class U-nat, the bone is the critical organ. For W-elass U-nat, the lung or the bone is the critical organ, depending on particle size. For Y-clase ; the lung is the critical organ.
Although the bone is the critical organ for D-class U-nat, this annual dose equivalent will not be reached until at least five years of inhalation have accumulated (Table 6 )j urinalysis would detect the intake long before this occurred. Activity in the kidney woulri also be revealed by urinalysis before it reached 1 kidney burden, as Table 7 shows. Similarly, chronic inhalation of W-class material would be detected by routine urine sampling.
Because it is already nucensary to perform semiannual lung counts (to assure ^15 reo/ycar from acute exposures), it is assumed that the deposit in the lung from chronic exposure vould be detected at one of the&e counts long before equilibrium would be established (see Table 6 ). An equilibrium level of 9 nCi in the lung will deliver a dose equivalent rate of 12.9 rem/year.
CONCLUSIONS
For a single inhalation exposure to natural uranium, the kidney is the critical organ for D-class and W-claas materials. For Y-class U-nat, the lung is the critical organ.
With the NRC minimum detection limit of S ug/1 of natural uranium in the urine, urinalysis on a worker should be performed at least every three weeka if the uranium taken into the body is of D-class solubility.
This should assure detection of an intake before it exceeds 1 kidney burden. The NHC Regulatory Guide 8.22 recommends that workers be sampled every two weeks. 
The number of atoms in 1 g of natural uranium is 
Complexity arises, however, because new material is being added daily to the blood from deposits in the NP, TB, PL, and LY regions. As long as there are deposits in any one of these regions, there is a day 1 situation for the material added that day. It is therefore necessary to sum all the previous days' contribution to the Bystemlc burden. Therefore, the urine output on any day may be given by where X represents the biological decay constants or the material in NP, TB, etc., regions destined to go to the blood, and the q values are the quantity in activity units deposited in each region. This can beat be explained by an example. From the computer printout we obtain the following values for t = 30 days: 
